Patients Stopping Slimming Jabs Put On Weight at a Quadrupled Rate Compared to People Using Diet and Exercise
A recent study suggests that patients who come off popular slimming jabs like Wegovy and Mounjaro tend to recover lost weight far faster than those who stop conventional lifestyle programs.
Published data in a leading medical journal demonstrates that while obese people can lose substantial amounts of their body weight while on the medication, the mass is regained at an estimated rate of nearly a kilo each month once they quit.
"Users purchasing such drugs must be aware of the risk of quick rebound weight gain when the medication ends," cautioned researcher Dr. Susan Jebb.
That rate of recovery implies a return to pre-treatment mass within about one and a half years.
Analyzing Treatments
The study, which examined 37 of trials involving thousands of patients, contrasted the effects of the injectable medications with other pills.
Scientists point out that individuals who lose weight through lifestyle changes alone generally experience a less rapid weight regain—approximately 100 grams monthly—after stopping.
The Reason for the Quick Regain
Doctors propose the mechanism of the injections is key to understanding the heightened weight return.
GLP-1 drugs copy a body's own chemical called glucagon-like peptide-1, which moderates hunger.
"Sustained high doses of the hormone levels far above than normal could lead to the body to generate a reduced amount of its endogenous GLP-1, and may also lessen sensitivity to its actions," explained Dr. Adam Collins, a nutrition specialist.
"Discontinuation of this hormone supplement means hunger is uncontrolled, making overeating a significant risk."
A Chronic Issue?
Health authorities suggest the injections for individuals with obesity-related medical conditions, accompanied by prescribed diet and exercise modifications.
A number of clinicians say that, given the likelihood of relapse, the treatment is often long-term.
This opinion is reinforced by drug manufacturers, who state that the results "highlight the persistent nature of excess weight," akin to managing diseases like high blood pressure.
Patient Testimonies
Individuals who have discontinued the medication explain a intense resurgence of hunger.
"It felt as if a trigger activating and I was suddenly starving," described a patient.
This difficulty is exacerbated if individuals have not adopted sustainable dietary or behavioural changes during therapy.
Significant Interest
Survey data indicate that millions of adults in the UK have used weight-loss jabs in the past year, with desire being substantial.
- Use is more common among women compared to males.
- The 40s and 50s demographic shows the highest usage rates.
- Many obtain the drugs through private healthcare rather than the NHS.
Finally, experts stress that while GLP-1 drugs are powerful agents for shedding pounds, they are not a standalone fix and lasting health benefits hinges on integrated behavioural changes.
